Nathaniel R Landau

Author PubWeight™ 83.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003 9.48
2 Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat Struct Mol Biol 2004 6.26
3 A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci U S A 2002 4.52
4 SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med 2012 4.27
5 A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A 2004 3.73
6 APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr Biol 2006 3.57
7 APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J Biol Chem 2004 3.56
8 Complementary function of the two catalytic domains of APOBEC3G. Virology 2005 3.45
9 Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A 2003 2.71
10 HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc Natl Acad Sci U S A 2007 2.50
11 Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol 2005 2.17
12 Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. J Virol 2009 1.91
13 Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol 2008 1.86
14 Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J Virol 2011 1.85
15 CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 2012 1.85
16 Association of chemokine-mediated block to HIV entry with coreceptor internalization. J Biol Chem 2002 1.79
17 Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G. J Virol 2006 1.69
18 Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. PLoS Pathog 2009 1.65
19 Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. Virology 2009 1.50
20 The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol 2012 1.47
21 The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 2003 1.40
22 Recent insights into HIV-1 Vif. Curr Opin Immunol 2004 1.30
23 Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. J Biol Chem 2006 1.30
24 Restriction of diverse retroviruses by SAMHD1. Retrovirology 2013 1.23
25 Chimeric human immunodeficiency virus type 1 containing murine leukemia virus matrix assembles in murine cells. J Virol 2002 1.15
26 The cargo-binding domain of transportin 3 is required for lentivirus nuclear import. J Virol 2011 1.09
27 Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 2004 1.06
28 HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology 2003 1.00
29 Accessories to the crime: recent advances in HIV accessory protein biology. Curr HIV/AIDS Rep 2009 0.96
30 New insights into the role of Vif in HIV-1 replication. AIDS Rev 2004 0.95
31 HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx. AIDS Res Hum Retroviruses 2013 0.94
32 Inhibition of CUL4A Neddylation causes a reversible block to SAMHD1-mediated restriction of HIV-1. J Virol 2013 0.92
33 Inhibition of HIV-1 infection by a CCR5-binding cyclophilin from Toxoplasma gondii. Blood 2003 0.91
34 Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells. Virology 2002 0.88
35 Analysis of Vif-induced APOBEC3G degradation using an alpha-complementation assay. Virology 2006 0.81
36 Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest. Virol J 2014 0.78
37 Production and use of HIV-1 luciferase reporter viruses. Curr Protoc Pharmacol 2003 0.76
38 SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies. bioRxiv 2022 0.75
39 A cellular cofactor in HIV-1 assembly: INI1 is also an "outtie". Trends Pharmacol Sci 2002 0.75